These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1024 related articles for article (PubMed ID: 14998500)

  • 21. Dynamics of Streptococcus pneumoniae nasopharyngeal carriage with high heptavalent pneumococcal conjugate vaccine coverage in Central Greece.
    Grivea IN; Tsantouli AG; Michoula AN; Syrogiannopoulos GA
    Vaccine; 2011 Nov; 29(48):8882-7. PubMed ID: 21963873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serological criteria and carriage measurement for evaluation of new pneumococcal vaccines.
    Principi N; Esposito S
    Hum Vaccin Immunother; 2015; 11(6):1494-500. PubMed ID: 25970715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings.
    Cheung YB; Zaman SM; Nsekpong ED; Van Beneden CA; Adegbola RA; Greenwood B; Cutts FT
    Pediatr Infect Dis J; 2009 Nov; 28(11):990-5. PubMed ID: 19536041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pneumococcal vaccines: an update on current strategies.
    Bogaert D; Hermans PW; Adrian PV; Rümke HC; de Groot R
    Vaccine; 2004 Jun; 22(17-18):2209-20. PubMed ID: 15149779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laboratory surveillance of invasive pneumococcal disease in Australia in 2001 to 2002--implications for vaccine serotype coverage.
    Watson M; Bayley K; Bell JM; Gilbert GL; Hogg G; Keil AD; Krause V; Murphy D; Roche P; Smith HV; Stewart MG; Stylianopoulos J; Turnidge J
    Commun Dis Intell Q Rep; 2003; 27(4):478-87. PubMed ID: 15508501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines.
    Picazo JJ
    Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():4-6. PubMed ID: 19366362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in Streptococcus pneumoniae serotype distribution in invasive disease and nasopharyngeal carriage after the heptavalent pneumococcal conjugate vaccine introduction in Bogotá, Colombia.
    Parra EL; De La Hoz F; Díaz PL; Sanabria O; Realpe ME; Moreno J
    Vaccine; 2013 Aug; 31(37):4033-8. PubMed ID: 23680440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae.
    Dagan R
    Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():16-20. PubMed ID: 19366365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pneumococcal conjugate vaccines. A review.
    Galiza EP; Heath PT
    Minerva Med; 2007 Apr; 98(2):131-43. PubMed ID: 17519855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colonisation endpoints in Streptococcus pneumoniae vaccine trials.
    Auranen K; Rinta-Kokko H; Goldblatt D; Nohynek H; O'Brien KL; Satzke C; Simell B; Tanskanen A; Käyhty H;
    Vaccine; 2013 Dec; 32(1):153-8. PubMed ID: 24016803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members.
    Millar EV; Watt JP; Bronsdon MA; Dallas J; Reid R; Santosham M; O'Brien KL
    Clin Infect Dis; 2008 Oct; 47(8):989-96. PubMed ID: 18781875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamics of nasopharyngeal bacterial colonisation in HIV-exposed young infants in Tanzania.
    Kinabo GD; van der Ven A; Msuya LJ; Shayo AM; Schimana W; Ndaro A; van Asten HA; Dolmans WM; Warris A; Hermans PW
    Trop Med Int Health; 2013 Mar; 18(3):286-95. PubMed ID: 23320622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease.
    Hammitt LL; Bruden DL; Butler JC; Baggett HC; Hurlburt DA; Reasonover A; Hennessy TW
    J Infect Dis; 2006 Jun; 193(11):1487-94. PubMed ID: 16652275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The future of pneumococcal disease prevention.
    Rodgers GL; Klugman KP
    Vaccine; 2011 Sep; 29 Suppl 3():C43-8. PubMed ID: 21896352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regional differences in serotype distribution, pneumococcal vaccine coverage, and antimicrobial resistance of invasive pneumococcal disease among German federal states.
    Imöhl M; Reinert RR; van der Linden M
    Int J Med Microbiol; 2010 Apr; 300(4):237-47. PubMed ID: 19604721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of community-wide conjugate pneumococcal vaccine use in infancy on nasopharyngeal carriage through 3 years of age: a cross-sectional study in a high-risk population.
    Millar EV; O'Brien KL; Watt JP; Bronsdon MA; Dallas J; Whitney CG; Reid R; Santosham M
    Clin Infect Dis; 2006 Jul; 43(1):8-15. PubMed ID: 16758412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine era.
    Zuccotti G; Mameli C; Daprai L; Garlaschi ML; Dilillo D; Bedogni G; Faccini M; Gramegna M; Torresani E; ; Ballerini E; Benincaso A; Bonvissuto M; Bricalli D; Brioschi M; Calloni CS; Camiletti MI; Colella G; De Angelis L; Decarlis S; Di Nello F; Dozzi M; Galli E; Gandini V; Giuliani MG; Laviola F; Loda B; Macedoni M; Mazzucchi E; Metta MG; Moscatiello A; Nannini P; Petruzzi M; Picicco D; Picciotti M; Pisanelli S; Porta N; Ramponi G; Redaelli F; Rubini R; Sala N; Saitta V; Scelza G; Tiso RM; Tomasetto M; Torcoletti M; Travaini M; Valentini M; Vessia C
    Vaccine; 2014 Jan; 32(5):527-34. PubMed ID: 24342249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design questions for Streptococcus pneumoniae vaccine trials with a colonisation endpoint.
    Auranen K; Rinta-Kokko H; Goldblatt D; Nohynek H; O'Brien KL; Satzke C; Simell B; Tanskanen A; Käyhty H
    Vaccine; 2013 Dec; 32(1):159-64. PubMed ID: 23871614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiologic characteristics, serotypes, and antimicrobial susceptibilities of invasive Streptococcus pneumoniae isolates in a nationwide surveillance study in Lebanon.
    Hanna-Wakim R; Chehab H; Mahfouz I; Nassar F; Baroud M; Shehab M; Pimentel G; Wasfy M; House B; Araj G; Matar G; Dbaibo G;
    Vaccine; 2012 Dec; 30 Suppl 6():G11-7. PubMed ID: 23228352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nasopharyngeal carriage of Streptococcus pneumoniae in Taiwan before and after the introduction of a conjugate vaccine.
    Kuo CY; Hwang KP; Hsieh YC; Cheng CH; Huang FL; Shen YH; Huang YC; Chiu CH; Chen PY; Lin TY
    Vaccine; 2011 Jul; 29(32):5171-7. PubMed ID: 21621578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.